BACKGROUND: Q fever is a zoonosis caused by the obligate intracellular bacterium Coxiella burnetii. The two long-term complications, after primary infection, are chronic Q fever in ∼1% of patients, and a chronic fatigue syndrome in 10-20%. However, the existence of a protracted decreased health status after Q fever remains controversial. AIM: To determine the health status of the patients of the Q fever outbreak in The Netherlands in 2007, 1 year after primary infection. DESIGN: Cross-sectional case-control study. METHODS: Health status of the patients from the 2007 Dutch Q fever outbreak was compared to age-, sex- and geographically matched and Q fever seronegative controls. Health status of both patients and controls was assessed with the Nijmegen Clinical Screening Instrument (NCSI). RESULTS: Fifty-four Q fever patients provided 34 years of age- and sex-matched controls from the same neighbourhood. Eleven controls had positive Q fever serology and were excluded. Q fever patients had significantly more problems on the subdomains of symptoms and functional impairment. Overall quality of life was decreased in both patients and controls, 59% vs. 39%, respectively, ns). Severe fatigue levels were present in 52% of patients vs. 26% in controls (P < 0.05). CONCLUSION: These data support a sustained decrease in many aspects of health status in Q fever patients in The Netherlands, 1 year after primary infection.
BACKGROUND: Q fever is a zoonosis caused by the obligate intracellular bacterium Coxiella burnetii. The two long-term complications, after primary infection, are chronic Q fever in ∼1% of patients, and a chronic fatigue syndrome in 10-20%. However, the existence of a protracted decreased health status after Q fever remains controversial. AIM: To determine the health status of the patients of the Q fever outbreak in The Netherlands in 2007, 1 year after primary infection. DESIGN: Cross-sectional case-control study. METHODS: Health status of the patients from the 2007 Dutch Q fever outbreak was compared to age-, sex- and geographically matched and Q fever seronegative controls. Health status of both patients and controls was assessed with the Nijmegen Clinical Screening Instrument (NCSI). RESULTS: Fifty-four Q feverpatients provided 34 years of age- and sex-matched controls from the same neighbourhood. Eleven controls had positive Q fever serology and were excluded. Q feverpatients had significantly more problems on the subdomains of symptoms and functional impairment. Overall quality of life was decreased in both patients and controls, 59% vs. 39%, respectively, ns). Severe fatigue levels were present in 52% of patients vs. 26% in controls (P < 0.05). CONCLUSION: These data support a sustained decrease in many aspects of health status in Q feverpatients in The Netherlands, 1 year after primary infection.
Authors: Joseph G Graham; Laura J MacDonald; S Kauser Hussain; Uma M Sharma; Richard C Kurten; Daniel E Voth Journal: Cell Microbiol Date: 2013-01-14 Impact factor: 3.715
Authors: J A F van Loenhout; C C H Wielders; G Morroy; M J M Cox; W van der Hoek; J L A Hautvast; W J Paget; J van der Velden Journal: Epidemiol Infect Date: 2015-01-13 Impact factor: 4.434
Authors: J C J P Hagenaars; P C Wever; S O A Shamelian; A S Van Petersen; M Hilbink; N H M Renders; G L De Jager-Leclercq; F L Moll; O H J Koning Journal: Epidemiol Infect Date: 2015-01-22 Impact factor: 4.434
Authors: Gabriëlla Morroy; Jeannette B Peters; Malou van Nieuwenhof; Hans H J Bor; Jeannine L A Hautvast; Wim van der Hoek; Clementine J Wijkmans; Jan H Vercoulen Journal: BMC Infect Dis Date: 2011-04-18 Impact factor: 3.090
Authors: Joris A F van Loenhout; W John Paget; Gerwin W Sandker; Jeannine L A Hautvast; Koos van der Velden; Jan H Vercoulen Journal: Health Qual Life Outcomes Date: 2013-07-04 Impact factor: 3.186
Authors: Gabriella Morroy; Stephan P Keijmel; Corine E Delsing; Gijs Bleijenberg; Miranda Langendam; Aura Timen; Chantal P Bleeker-Rovers Journal: PLoS One Date: 2016-05-25 Impact factor: 3.240
Authors: Punsiri M Colonne; Caylin G Winchell; Joseph G Graham; Frances I Onyilagha; Laura J MacDonald; Heike R Doeppler; Peter Storz; Richard C Kurten; Paul A Beare; Robert A Heinzen; Daniel E Voth Journal: PLoS Pathog Date: 2016-10-06 Impact factor: 6.823
Authors: Joris Af van Loenhout; W John Paget; Jan H Vercoulen; Clementine J Wijkmans; Jeannine L A Hautvast; Koos van der Velden Journal: BMC Infect Dis Date: 2012-10-30 Impact factor: 3.090
Authors: A S G van Dam; J A F van Loenhout; J B Peters; A Rietveld; W J Paget; R P Akkermans; A Olde Loohuis; J L A Hautvast; J van der Velden Journal: Epidemiol Infect Date: 2014-03-14 Impact factor: 4.434